Skip to main content

Find Clinical Trials

Home
Conditions
Glioblastoma

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

644 public trials 152 recruiting studies

Refine in advanced search Browse all conditions

Glioblastoma trial results

Completed

Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme

NCT01604590

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma

NCT00694837

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Maastricht Radiation Oncology Maastricht, Netherlands

View Trial Details

Completed

Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)

NCT00723827

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Not specified

View Trial Details

Completed

A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas

NCT00734682

Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Astrocytoma, +11 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma

NCT00525525

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

Sorafenib in Newly Diagnosed High Grade Glioma

NCT00884416

Conditions: Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, +12 more
Locations: Geneva University Hospital (Hopitaux Universitaires de Geneve), Department of Oncology Geneva, Canton of Geneva, Switzerland

View Trial Details

Completed

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status

NCT00689221

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States

Please Contact the Merck KGaA Communication Center Located in Darmstadt, Germany

View Trial Details

Completed

Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma

NCT00576641

Conditions: Astrocytoma, Brain Stem Glioma, Glioblastoma, +8 more
Locations: Cedars Sinai Medical Center Los Angeles, California, United States

View Trial Details

Completed

Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma

NCT00960492

Conditions: Astrocytoma, Giant Cell Glioblastoma, Glioblastoma, +9 more
Locations: UCLA Los Angeles, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Henry Ford Health System Detroit, Michigan, United States

Beth Israel Medical Center New York, United States

View Trial Details

Completed

Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide

NCT00616005

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details